A retrospective observational study of trifluridine tipiracil plus minus bevacizumab in pretreated mCRC patients with MSI-H MMR-D metastatic colorectal cancer
Not Applicable
- Conditions
- Metastatic colorectal cancer with microsatellite instability high (MSI-H) mismatch repair deficient (MMR-D)
- Registration Number
- JPRN-UMIN000051378
- Lead Sponsor
- The 22nd Century Cutting-Edge Medical Informaion Technology Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1.Presence of multiple life threatening cancers 2.Inappropriate cases by physicians judgement
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method